If you do drink, go slow, stay hydrated, and keep the amount modest
Summary of study design: Schedule and size: Outcomes: Critiques of the study design: Operational and technical challenges: Overall, while the design of the phase 1 study for CT-388 is within standard protocols for new therapeutic agents, certain details of the design and operational aspects would benefit from further clarification
Transcription factor STAT3 as a novel molecular target for cancer prevention
This allows enough time for the embryo to attach itself and hCG levels to rise, making the pregnancy detectable by most tests
, Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial, Lancet Diabetes Endocrinol
Gallbladder disease In patients with established gallbladder disease, the relative risks and benefits of a cholecystectomy or preventive treatment with ursodeoxycholic acid before starting GLP-1 receptor agonist therapy should be thoroughly discussed
